Strong enough for hospital environments, yet gentle enough for everyday family use, Hibiclens antiseptic skin cleanser helps provide effective germ protection wherever it’s needed.

Hibiclens begins working on contact to help kill germs present on the skin, making it suitable for both clinical and home hygiene routines. It is the #1 pharmacist-recommended antibacterial soap, trusted for its proven performance.³

Unlike ordinary soaps, Hibiclens doesn’t just clean the skin—it continues working after use. Its active ingredient, 4% chlorhexidine gluconate (CHG), binds to the skin to provide extended antimicrobial protection against a broad range of bacteria, helping reduce the risk of infection even after rinsing. It is formulated to be gentle enough for frequent use without leaving behind a sticky residue.¹

Who can benefit from Hibiclens?

Families – People regularly come into contact with hundreds of surfaces throughout the day, exposing them to large numbers of germs. Using Hibiclens as part of routine hand hygiene can help reduce this exposure and support everyday protection.

Caregivers – Ideal for those caring for others, Hibiclens offers a balance of strong germ-killing action and gentle daily usability, helping protect both caregiver and patient.

Pre- and post-operative use – Commonly recommended in healthcare settings before and after procedures, Hibiclens supports skin cleansing routines aimed at reducing the risk of surgical site infections (SSIs).

How Hibiclens works
Its active ingredient, 4% CHG, helps reduce bacteria that may cause infection. After rinsing, it leaves behind a protective layer that continues working without residue, supporting ongoing antimicrobial activity.

Do I need a prescription?
No. Hibiclens is available over the counter at most major and local retailers, typically in the First Aid section. While healthcare professionals may recommend its use in specific cases, a prescription is not required.

References: PRACs Report #R05-0225; Paulson, Daryl S., Infection Control Today (2005); Pharmacy Times OTC Survey (2025); 2012 Tork Report.